Randomized phase II study of S-1 and concurrent radiotherapy with versus without induction chemotherapy of gemcitabine for locally advanced pancreatic cancer (JCOG1106)

被引:1
|
作者
Fukutomi, Akira
Mizusawa, Junki
Katayama, Hiroshi
Nakamura, Satoaki
Ito, Yoshinori
Hiraoka, Nobuyoshi
Ioka, Tatsuya
Ueno, Makoto
Ikeda, Masafumi
Sugimori, Kazuya
Shimizu, Kyoko
Okusaka, Takuji
Ozaka, Masato
Yanagimoto, Hiroaki
Nakamori, Shoji
Azuma, Takeshi
Hosokawa, Ayumu
Sata, Naohiro
Mine, Tetsuya
Furuse, Junji
机构
[1] Shizuoka Canc Ctr, Div Gastrointestinal Oncol, Shizuoka, Japan
[2] Natl Canc Ctr, Clin Oncol Grp, Ctr Data, Ctr Res Adm & Support, Tokyo 104, Japan
[3] Kyoto Prefectural Univ Med, Dept Radiol, Kyoto, Japan
[4] Natl Canc Ctr, Dept Radiat Oncol, Tokyo, Japan
[5] Natl Canc Ctr, Div Pathol & Clin Labs, Tokyo, Japan
[6] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Hepatobiliary & Pancreat Oncol, Osaka, Japan
[7] Kanagawa Canc Ctr, Div Hepatobiliary & Pancreat Oncol, Yokohama, Kanagawa 2410815, Japan
[8] Natl Canc Ctr Hosp East, Dept Hepatobiliary & Pancreat Oncol, Kashiwa, Chiba, Japan
[9] Yokohama City Univ, Gastroenterol Ctr, Med Ctr, Yokohama, Kanagawa 232, Japan
[10] Tokyo Womens Med Univ, Inst Gastroenterol, Tokyo, Japan
[11] Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Tokyo, Japan
[12] Japanese Fdn Canc Res, Canc Inst Hosp, Hepatobiliary & Pancreat Div, Tokyo, Japan
[13] Kansai Med Univ, Hirakata Hosp, Dept Surg, Hirakata, Osaka, Japan
[14] Osaka Natl Hosp, Dept Hepatobiliary & Pancreat Surg, Osaka, Japan
[15] Kobe Univ, Dept Internal Med, Sch Med, Div Gastroenterol, Kobe, Hyogo 657, Japan
[16] Toyama Univ, Dept Gastroenterol & Hematol, Fac Med, Toyama 930, Japan
[17] Jichi Med Univ, Sch Med, Dept Surg, Shimotsuke, Japan
[18] Tokai Univ, Sch Med, Dept Gastroenterol & Hepatol, Isehara, Kanagawa 25911, Japan
[19] Kyorin Univ, Sch Med, Dept Med Oncol, Tokyo, Japan
关键词
D O I
10.1200/jco.2015.33.15_suppl.4116
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4116
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Randomized phase II study of S-1 and concurrent radiotherapy with versus without induction chemotherapy of gemcitabine for locally advanced pancreatic cancer (LAPC): Final analysis of JCOG1106
    Ioka, T.
    Fukutomi, A.
    Mizusawa, J.
    Katayama, H.
    Nakamura, S.
    Ito, Y.
    Hiraoka, N.
    Ueno, M.
    Ikeda, M.
    Sugimori, K.
    Shimizu, K.
    Okusaka, T.
    Ozaka, M.
    Yanagimoto, H.
    Nakamori, S.
    Azuma, T.
    Hosokawa, A.
    Sata, N.
    Mine, T.
    Furuse, J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [2] Randomized phase II study of chemoradiotherapy with versus without induction chemotherapy for locally advanced pancreatic cancer: Japan Clinical Oncology Group trial, JCOG1106
    Ioka, Tatsuya
    Furuse, Junji
    Fukutomi, Akira
    Mizusawa, Junki
    Nakamura, Satoaki
    Hiraoka, Nobuyoshi
    Ito, Yoshinori
    Katayama, Hiroshi
    Ueno, Makoto
    Ikeda, Masafumi
    Sugimori, Kazuya
    Okano, Naohiro
    Shimizu, Kyoko
    Yanagimoto, Hiroaki
    Okusaka, Takuji
    Ozaka, Masato
    Todaka, Akiko
    Nakamori, Shoji
    Tobimatsu, Kazutoshi
    Sata, Naohiro
    Kawashima, Yohei
    Hosokawa, Ayumu
    Yamaguchi, Taketo
    Miyakawa, Hiroyuki
    Hara, Hiroki
    Mizuno, Nobumasa
    Ishii, Hiroshi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (02) : 235 - 243
  • [3] A Phase 1 Study of Gemcitabine and S-1 Concurrent Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
    Matsumura, Yuji
    Suyama, Masafumi
    Sai, Jinkan
    Kubokawa, Yoshihiro
    Kamiya, Takayoshi
    Watanabe, Sumio
    PANCREAS, 2011, 40 (05) : 799 - 800
  • [4] A phase II study of oral S-1 with concurrent radiotherapy followed by chemotherapy with S-1 alone for locally advanced pancreatic cancer
    Shinchi, Hiroyuki
    Maemura, Kosei
    Mataki, Yuko
    Kurahara, Hiroshi
    Sakoda, Masahiko
    Ueno, Shinichi
    Hiraki, Yoshiyuki
    Nakajo, Masayuki
    Natsugoe, Shoji
    Takao, Sonshin
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2012, 19 (02) : 152 - 158
  • [5] A phase II study of induction chemotherapy with gemcitabine plus S-1 followed by chemoradiotherapy for locally advanced pancreatic cancer
    Kohei Nakachi
    Junji Furuse
    Taira Kinoshita
    Mitsuhiko Kawashima
    Hiroshi Ishii
    Masafumi Ikeda
    Shuichi Mitsunaga
    Satoshi Shimizu
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 527 - 534
  • [6] A phase II study of induction chemotherapy with gemcitabine plus S-1 followed by chemoradiotherapy for locally advanced pancreatic cancer
    Nakachi, Kohei
    Furuse, Junji
    Kinoshita, Taira
    Kawashima, Mitsuhiko
    Ishii, Hiroshi
    Ikeda, Masafumi
    Mitsunaga, Shuichi
    Shimizu, Satoshi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (03) : 527 - 534
  • [7] Phase I/II study of gemcitabine plus S-1 with concurrent radiotherapy in patients of unresectable locally advanced pancreatic cancer
    Ioka, Tatsuya
    Katayama, Kazuhiro
    Ishida, Nobuko
    Sueyoshi, Hironari
    Takada, Ryoji
    Yamai, Takuo
    Fukutake, Nobuyasu
    Ashida, Reiko
    Akita, Hirofumi
    Takahashi, Hidenori
    Kawaguchi, Yoshifumi
    Konishi, Koji
    Teshima, Teruki
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [8] Phase II study of induction gemcitabine and S-1 followed by chemoradiotherapy and systemic chemotherapy using S-1 for locally advanced pancreatic cancer
    Kentaro Sudo
    Ryusuke Hara
    Kazuyoshi Nakamura
    Emiri Kita
    Akiko Tsujimoto
    Taketo Yamaguchi
    Cancer Chemotherapy and Pharmacology, 2017, 80 : 195 - 202
  • [9] Phase II study of induction gemcitabine and S-1 followed by chemoradiotherapy and systemic chemotherapy using S-1 for locally advanced pancreatic cancer
    Sudo, Kentaro
    Hara, Ryusuke
    Nakamura, Kazuyoshi
    Kita, Emiri
    Tsujimoto, Akiko
    Yamaguchi, Taketo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (01) : 195 - 202
  • [10] A phase I/II study of fixed-dose-rate gemcitabine and S-1 with concurrent radiotherapy for locally advanced pancreatic cancer
    Takahiro Goji
    Tetsuo Kimura
    Hiroshi Miyamoto
    Masanori Takehara
    Kaizo Kagemoto
    Yasuyuki Okada
    Jun Okazaki
    Yoshifumi Takaoka
    Yoshihiko Miyamoto
    Yasuhiro Mitsui
    Sayo Matsumoto
    Tatsuhisa Sueuchi
    Kumiko Tanaka
    Yasuteru Fujino
    Toshi Takaoka
    Shinji Kitamura
    Koichi Okamoto
    Masako Kimura
    Masahiro Sogabe
    Naoki Muguruma
    Toshiya Okahisa
    Yasuhiro Sato
    Tamotsu Sagawa
    Koji Fujikawa
    Yasushi Sato
    Hitoshi Ikushima
    Tetsuji Takayama
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 615 - 620